First-in-human results of STX-478, a mutant-selective PI3Ka inhibitor, in advanced solid tumor patients Meeting Abstract
| Authors: | Montero, A. J.; Giordano, A.; Jhaveri, K.; Munster, P.; Rodon, J.; Lorusso, P.; Orr, D.; Bartolomé Arcilla, J.; Italiano, A.; Elias, A.; Soyano, A.; De Miguel, M.; Doger de Spéville, B.; Daniele, G.; O'Shaughnessy, J.; Hernandez Guerrero, T. C.; Wesolowski, R.; Manich, C. S.; Chao, M.; Juric, D. |
| Abstract Title: | First-in-human results of STX-478, a mutant-selective PI3Ka inhibitor, in advanced solid tumor patients |
| Meeting Title: | ESMO Congress 2024 |
| Journal Title: | Annals of Oncology |
| Volume: | 35 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2024 Sept 13-17 |
| Meeting Location: | Barcelona, Spain |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2024-09-01 |
| Start Page: | 1220 |
| Language: | English |
| ACCESSION: | WOS:001326612903035 |
| DOI: | 10.1016/j.annonc.2024.08.2266 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: LBA27 -- Source: Wos |
